← Back to Clinical Trials
Recruiting NCT07057115

NCT07057115 Comparison of vNOTES and Laparoscopic Salpingectomy in the Surgical Treatment of Ectopic Pregnancy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07057115
Status Recruiting
Phase
Sponsor Gaziosmanpasa Research and Education Hospital
Condition Ectopic Pregnancy
Study Type INTERVENTIONAL
Enrollment 56 participants
Start Date 2025-07-01
Primary Completion 2026-01-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
vNOTES Salpingectomy Group.Laparoscopic Salpingectomy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 56 participants in total. It began in 2025-07-01 with a primary completion date of 2026-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study compares vNOTES salpingectomy and laparoscopic salpingectomy in the treatment of ectopic pregnancy, focusing on outcomes such as operative time, postoperative pain, and recovery.

Eligibility Criteria

Inclusion Criteria: Women diagnosed with ectopic pregnancy Without heterotopic pregnancy Women aged 18-55 years, within reproductive age Patients for whom medical treatment is not appropriate Patients requiring surgical intervention Patients without systemic diseases that may contraindicate surgery Patients who have signed and approved the informed consent form to participate in the study Exclusion Criteria: Ectopic pregnancy cases that can be treated with medical therapy Patients with advanced pelvic infections or pelvic anatomical abnormalities Patients with immunodeficiency or systemic diseases that contraindicate surgery

Contact & Investigator

Central Contact

yağmur aciyiyen, md

✉ yagmuraciyiyen@gmail.com

📞 +90 5425669593

Principal Investigator

havva betül bacak, md

PRINCIPAL INVESTIGATOR

Gaziosmanpaşa training and research hospital

Frequently Asked Questions

Who can join the NCT07057115 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 55 Years, studying Ectopic Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07057115 currently recruiting?

Yes, NCT07057115 is actively recruiting participants. Contact the research team at yagmuraciyiyen@gmail.com for enrollment information.

Where is the NCT07057115 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07057115 clinical trial?

NCT07057115 is sponsored by Gaziosmanpasa Research and Education Hospital. The principal investigator is havva betül bacak, md at Gaziosmanpaşa training and research hospital. The trial plans to enroll 56 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology